Impact of Haskap Berries on Recovery From High Intensity Resistance Training
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this clinical trial is to determine how certain food items affect oxidative stress, inflammation, and performance recovery from exercise induced muscle damage in a resistance trained population. The main questions The investigators aim to answer are the following:
- Do Haskaps speed the recovery of oxidative stress and inflammation markers after an intense lower body workout in resistance trained adults?
- Do Haskaps speed the recovery of performance measures after an intense lower body workout in resistance trained adults?
- The data collected in this investigation may also be used to ask additional questions not yet identified. For example, the investigators may use the stored samples to evaluate how the blood metabolites of participants differ before and after intense exercise. These additional questions are called secondary analyses. Please note that no genetic analysis will be conducted and racial and ethnic differences among participants will not be used in any secondary analyses. Researches will compare Haskap juice to a color, flavor and carbohydrate matched placebo to see if Haskaps speed recovery in inflammation, oxidative stress and performance.
- Participants will be asked to drink either Haskap juice or placebo and follow a low polyphenolic diet
- Participants will perform an intense resistance workout
- Participants will have their blood drawn before and after the workout
- Performance will be analyzed at 24, 48 and 72 hours after the workout
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 21, 2025
CompletedFirst Submitted
Initial submission to the registry
January 7, 2026
CompletedFirst Posted
Study publicly available on registry
January 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedJanuary 21, 2026
January 1, 2026
4 months
January 7, 2026
January 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Force Production
Maximal Voluntary Contraction (MVC) to assess force production of knee extensors at 60 degrees.
72 hours
Barbell Velocity
Barbell velocity will be measure to determine how squat velocity recovers over the course of the study.
72 hours
Vertical Jump
Force plates will be used to evaluate vertical jump height.
72 hours
Inflammation (pg/mL)
Serum interleukin (IL) IL-6, IL-10, IL-1ra, tumor necrosis factor alpha (TNF-alpha),
11 days
Lipid peroxidation
Plasma Malondialdehyde (MDA)
11 days
Creatine Kinase
Plasma
11 days
C-Reactive Protein
Plasma
11 days
Protein Carbonyls
Plasma
11 days
Secondary Outcomes (3)
Soreness
72 hours
Acute Diet
9 days
Sleep Questionnaire
11 days
Study Arms (2)
Placebo Control
PLACEBO COMPARATORThe placebo supplement will have no polyphenol content and will be carbohydrate-matched to the experimental group. A twice daily dose (10-12 hours apart) will be consumed for 11 days.
Haskap
EXPERIMENTALThe haskap supplement will consist of a haskap berry smoothie. A twice daily dose (10-12) hours apart will be consumed for 11 days.
Interventions
A smoothie with no polyphenolic content and matched in carbohydrate composition to the experimental haskap smoothie
Eligibility Criteria
You may qualify if:
- + years of barbell squat experience
- Currently squatting at least once a week
You may not qualify if:
- BMI \<18 or \> 40 kg/m\^2
- potential allergy to Haskap or placebo ingredients
- anti-inflammatory, weight loss, anabolic steroids, testosterone, or other drugs that may interfere with the measures of the study or any other medications that may interfere with study measures
- pregnant or lactating woman
- diagnosis with type 1 or type 2 diabetes, hypo-/hyperthyroidism or any other condition that may interfere with study measures
- smoke cigarettes
- lower extremity injury within the last year
- currently following a special diet including vegan, vegetarian, low carbohydrate, or ketogenic.
- currently consuming any of the following products: tart cherry juice, pomegranate juice, or 1 or more cups of acai or other berries per day.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Montana State University
Bozeman, Montana, 59715, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary P Miles
Montana State University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Placebo and haskap interventions were designed to be comparable in taste, carbohydrate content, and appearance.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2026
First Posted
January 15, 2026
Study Start
October 21, 2025
Primary Completion
March 1, 2026
Study Completion
May 1, 2026
Last Updated
January 21, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share